GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
SMS Pharmaceuticals Ltd

SMS Pharmaceuticals Ltd: Rs. 45.63 Crore Tax Demand Vacated

REGULATORY ▲ Positive Development LOW RISK
📅 Filed on BSE: 31 Oct 2026, 08:26 PM IST  ·  BSE ID: 7174721f-5f85-4be4-b100-73525bbca84f
View Original BSE Filing (PDF)
💡
In Simple Terms
SMS Pharmaceuticals won its tax appeal, and the Rs. 45.63 Crore tax demand against the company has been cancelled.
🤖 AI Summary
  • SMS Pharmaceuticals' appeal against a Rs. 45.63 Crores tax demand has been allowed by tax authorities.
  • The order from the Commissioner of Income Tax (Appeals) vacates the entire outstanding tax demand, including interest.
  • The original demand was related to the Income Tax Assessment Order for Assessment Year 2023-24.
  • The company filed an appeal following the assessment order dated March 22, 2025.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Tax Demand Vacated
Rs.45.63 Crores
Assessment Year
2023-24
Date of Appellate Order
30th October 2026
🏢 How This Affects the Company
💰
Financial Impact
The vacation of the Rs. 45.63 Crores tax demand, including interest, removes a significant contingent liability from the company's financial obligations.
⚠️
Risk Impact
This development reduces financial risk associated with potential tax penalties and past litigation.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders.
👤
Who Is Affected
All shareholders are affected by the removal of a significant contingent liability from the company's balance sheet.
🔍
Management Signal
This outcome signals effective financial stewardship and successful navigation of regulatory challenges by management.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Confirmation of financial statement impact reflecting vacated tax demand.
Next quarterly results announcement for FY27.
Company disclosures on any further tax-related matters.
LOW RISK The company has successfully resolved a significant tax demand, reducing financial risk.
💡 Investor Takeaway
SMS Pharmaceuticals' appeal has been allowed, vacating the Rs. 45.63 Crores tax demand, including interest, for Assessment Year 2023-24.
⚖️ Strengths & Concerns

✅ Positives

  • Successful appeal outcome vacates Rs. 45.63 Crores tax demand and interest, resolving a significant financial obligation.
  • Favorable appellate order from Commissioner of Income Tax (Appeals) confirms company's position on Assessment Year 2023-24 tax assessment.
📅 Company Track Record
This order follows a Rs. 7.19 Crores tax demand for FY 2018-19 that was previously dismissed, and a rectification order that slashed a demand to Rs. 40.28 Lakhs from Rs. 7.19 Crores.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What is the total tax demand vacated for SMS Pharmaceuticals?
SMS Pharmaceuticals' tax demand of Rs.45.63 Crores, including interest, has been vacated.
Which assessment year does this tax order pertain to?
This tax order pertains to the Assessment Year 2023-24.
Who issued the order allowing SMS Pharmaceuticals' appeal?
The order was issued by the Commissioner of Income Tax (Appeals), National Faceless Appeal Centre.
When was the appellate order received by SMS Pharmaceuticals?
The appellate order was received by SMS Pharmaceuticals on 30th October 2026.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.